The peripheral nervous system (PNS) is a vast communications network that transmits information from the brain and spinal cord (the central nervous system) to every other part of the body. Peripheral nerves (PN) also send sensory information back to the brain and spinal cord, such as a message that the feet are cold or a finger is burned.
The treatment of PNI is mostly based on surgery and by the use of nerve grafts and conduits. Pharmacological therapies to accelerate the nerve repair process is the current unmet need of PNI market. The market is expected to grow by factors like an increase in the patient pool, expected entry of emerging products, i.e., such as CelGro, NTX-001, and deeper penetration in the 7MM markets.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/peripheral-nerve-injuries-market
The Peripheral Nerve Injuries Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Peripheral Nerve Injuries market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Peripheral Nerve Injuries treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Peripheral Nerve Injuries Market Key Facts
-
In 2017, the total number of surgeries performed for Peripheral Nerve Injuries in the 7MM was estimated to be 1,703,459. Out of the total patients enrolling for surgeries, around 8-12% of them need surgical revision of former surgery.
-
The United States accounts for 42.30% of annual cases of PNI among the 7MM. In 2017, there were a total of 1,645,218 cases of PNI in the US.
-
Japan ranked second-highest for Peripheral Nerve Injuries cases among 7MM. In 2017, Japan had 848,800 PNI cases.
-
Among the European 5 countries, Italy had the highest cases of PNI with 412,612 cases, followed by France and the United Kingdom with 292,295 cases, and 276,320 cases, respectively. On the other hand, Spain had the lowest cases, i.e., 142,880 in 2017.
-
Based upon the extremities, PNI cases are subcategorized into Upper Extremities, and Lower Extremities. Out of total 3,889,176 cases of PNI in the 7MM in 2017, 2,795,535 cases were of upper Extremities, and 1,093,641 cases were of Lower Extremities.
Key Benefits of Peripheral Nerve Injuries Market Report
-
The market report provides an in-depth analysis of Peripheral Nerve Injuries Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.
-
The report will help in developing business strategies by understanding the Peripheral Nerve Injuries Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.
-
The market report covers the Peripheral Nerve Injuries current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.
-
The report provides a detailed assessment of the Peripheral Nerve Injuries market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors.
Peripheral Nerve Injuries Market
Peripheral Nerve Injuries market size is anticipated to increase in the coming years owing to the increasing population of Peripheral Nerve Injuries (PNI) in the 7MM. Availability of technologically advanced nerve repair and regeneration products and the expected launch of emerging therapies will also boost the Peripheral Nerve Injuries Market Growth.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Peripheral Nerve Injuries market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Peripheral Nerve Injuries market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Request for Sample @ Peripheral Nerve Injuries Therapeutics Market Assessment
Peripheral Nerve Injuries Epidemiology
The epidemiology section covers insights about the historical and current Peripheral Nerve Injuries patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Peripheral Nerve Injuries Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Peripheral Nerve Injuries market or expected to get launched in the market during the study period. The analysis covers Peripheral Nerve Injuries market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Peripheral Nerve Injuries Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Key companies in the Peripheral Nerve Injuries market include:
-
Toyobo
-
Polyganics
-
Axogen Corporation
-
Neuraptive Therapeutics
-
Silk Biomaterials
-
Orthocell Limited
And many others.
Peripheral Nerve Injuries therapies covered in the report include:
-
CelGro
-
NTX-001
-
SilkBridge
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Peripheral Nerve Injuries Competitive Intelligence Analysis
4. Peripheral Nerve Injuries Market Overview at a Glance
5. Peripheral Nerve Injuries Disease Background and Overview
6. Peripheral Nerve Injuries Patient Journey
7. Peripheral Nerve Injuries Epidemiology and Patient Population
8. Peripheral Nerve Injuries Treatment Algorithm, Current Treatment, and Medical Practices
9. Peripheral Nerve Injuries Unmet Needs
10. Key Endpoints of Peripheral Nerve Injuries Treatment
11. Peripheral Nerve Injuries Marketed Products
12. Peripheral Nerve Injuries Emerging Therapies
13. Peripheral Nerve Injuries Seven Major Market Analysis
14. Attribute Analysis
15. Peripheral Nerve Injuries Market Outlook (7 major markets)
16. Peripheral Nerve Injuries Access and Reimbursement Overview
17. KOL Views on the Peripheral Nerve Injuries Market.
18. Peripheral Nerve Injuries Market Drivers
19. Peripheral Nerve Injuries Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/peripheral-nerve-injuries-market
Latest Reports By DelveInsight
Peripheral nerve injuries Pipeline Insights
Peripheral nerve injuries Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across Peripheral Nerve Injuries Market.
Neuromodulation Devices Market
DelveInsight’s ‘Neuromodulation Devices -Market Insights, Competitive Landscape, and Market Forecast – 2026’ report delivers an in-depth understanding of Neuromodulation Devices and the historical and forecasted Neuromodulation Devices market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/